Cryotherapy for Local Recurrent Dermatofibrosarcoma Protuberans: Experience in 19 Patients

来源 :2016第五届国际(广州)癌症治疗论坛暨国际干细胞再生医学学会成立大会 | 被引量 : 0次 | 上传用户:ZGGILOVE
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive, cutaneous, malignant tumor characterized by a high propensity for local relapse.Wide and deep local excision with reconstructive surgery is the current standard therapy for DFSP, with a local recurrence rate (LRR) of nearly 40%.In this study, we cured 19 patients with local recurrence of DFSP with 39 sessions of percutaneous cryoablation performed between July 2004and August 2008.The LRRs after one, two and three cryosurgery sessions per patient were 68%, 54% and 0%,respectively.Moreover, the LRR did not differ with tumor location or size.Furthermore, all patients had a progression-free survival of>5 years.Only minor complications such as fever, local edema, mild nerve injury and local pain occurred, and were resolved within 1week with symptomatic treatment.In our experience,percutaneous cryoablation is a relatively safe and efficient technique for the treatment of local recurrence of DFSPs.
其他文献
会议
objective: to evaluate the safety and effectiveness of percutaneous irreversible electroporation in ablation of local advanced stage pancreatic cancer;methods: 21 patients with local advanced pancreat
会议
会议
会议
目的:使用不可逆电穿孔(IRE)消融技术治疗不可手术切除性局部进展胰腺癌,观察该技术治疗胰腺癌的安全性和疗效.方法:前瞻性观察IRE消融术后30d内不良反应并按照改良RECIST标准评价术后(30±7)d客观疗效.结果:共12例患者接受治疗,IRE手术均顺利完成,术后30d内不良反应有穿刺点疼痛(5例,占41.7%)、恶心呕吐(3例,占25%)、咳嗽、术后低血糖、低钾血症、胃壁和十二指肠水肿各2例
Aims: To evaluate the use of computed tomography image-guided percutaneous cryoablation for recurrent retroperitoneal soft tissue sarcomas (RPSs).Results: Adverse events were limited to grades 1 and 2
Objective usepre-cryosurgery and post-cryosurgery CTCs as tumor biomarkers to evaluate the efficacy of cryosurgery for unresectable hepatocellular carcinoma.Methods use the method of real-time qPCR to
Percutaneous cryoablation is a potentially curative treatment for hepatocellular carcinoma (HCC).After liver cryosurgery, rapid elevations of transaminases and bilirubin are common, but are usually tr
会议
Percutaneous cryoablation is a potential cure for hepatocellular carcinoma (HCC).This study reviewed retrospectively clinical data from 14 patients who underwent cryoablation of huge HCC (long diamete
会议
We compared imaging and pathological changes between argon-helium cryosurgical (AH) and microwave (MW)ablation in a porcine liver model.Immediately after ablation, computed tomography (CT) imaging sho
会议